| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
1,095,971,000 |
| Market
Cap: |
19.60(B) |
| Last
Volume: |
5,386,894 |
Avg
Vol: |
10,419,617 |
| 52
Week Range: |
$8.12 - $18.96 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
172,605 |
734,959 |
1,412,302 |
1,924,786 |
| Total Sell Value |
$2,987,942 |
$12,552,113 |
$21,526,718 |
$26,430,585 |
| Total People Sold |
3 |
6 |
10 |
12 |
| Total Sell Transactions |
4 |
8 |
22 |
37 |
| End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shalev Varda |
|
– • – |
2024-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,872 |
12,872 |
|
- |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2024-08-12 |
4 |
S |
$17.30 |
$1,711,447 |
D/D |
(98,943) |
0 |
|
100% |
|
| Grant Angus |
EVP, Business Development |
• – – |
2024-08-09 |
4 |
AS |
$17.28 |
$70,243 |
D/D |
(4,065) |
8,848 |
|
3% |
|
| Grant Angus |
EVP, Business Development |
• – – |
2024-08-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,913 |
12,913 |
|
- |
|
| Hughes Eric A |
See Remarks |
• – – |
2024-08-09 |
4 |
S |
$17.38 |
$782,972 |
D/D |
(45,060) |
0 |
|
100% |
|
| Hughes Eric A |
See Remarks |
• – – |
2024-08-01 |
4 |
AS |
$17.25 |
$423,280 |
D/D |
(24,537) |
45,060 |
|
-0% |
|
| Hughes Eric A |
See Remarks |
• – – |
2024-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
52,742 |
69,597 |
|
- |
|
| Mignone Roberto |
|
– • – |
2024-06-18 |
4 |
S |
$17.03 |
$8,838,570 |
I/I |
(519,000) |
981,000 |
|
100% |
|
| Crane Rosemary A |
|
– • – |
2024-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,108 |
103,615 |
|
- |
|
| Vergis Janet S. |
|
– • – |
2024-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,108 |
64,065 |
|
- |
|
| Nisen Perry |
|
– • – |
2024-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,108 |
95,683 |
|
- |
|
| Mignone Roberto |
|
– • – |
2024-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,108 |
1,595,683 |
|
- |
|
| Zaks Tal Zvi |
|
– • – |
2024-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,108 |
49,140 |
|
- |
|
| Lieberman Gerald M |
|
– • – |
2024-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,108 |
106,025 |
|
- |
|
| Barer Sol J |
|
– • – |
2024-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,598 |
409,114 |
|
- |
|
| Elstein Amir |
|
– • – |
2024-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,108 |
2,094,331 |
|
- |
|
| Satchi-Fainaro Ronit |
|
– • – |
2024-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,108 |
88,277 |
|
- |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2024-05-16 |
4 |
S |
$16.65 |
$210,377 |
D/D |
(12,635) |
5,179 |
|
100% |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2024-05-15 |
4 |
S |
$16.80 |
$260,417 |
D/D |
(15,500) |
17,814 |
|
100% |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-05-13 |
4 |
S |
$16.74 |
$254,807 |
D/D |
(15,219) |
0 |
|
100% |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2024-03-06 |
4 |
AS |
$13.52 |
$1,048,119 |
D/D |
(77,550) |
203,691 |
|
21% |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-03-05 |
4 |
AS |
$13.52 |
$19,286 |
D/D |
(1,427) |
15,219 |
|
23% |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,954 |
16,646 |
|
- |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,564 |
33,314 |
|
- |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
73,707 |
281,241 |
|
- |
|
541 Records found
|
|
Page 1 of 22 |
|
|
